I-131 therapy for Graves' disease with giant goiter

被引：0
|
作者：
Jinguji, M. [1 ]
Nakajo, M. [1 ]
Tani, A. [1 ]
Yoshiura, T. [1 ]
机构：
[1] Kagoshima Univ, Dept Radiol, Grad Sch Med & Dent Sci, Kagoshima, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0595
引用
收藏
页码：S654 / S655
页数：2
相关论文
共 50 条
  • [31] Accuracy of early I-131 uptake measurements in dose calculation for I-131 treatment of graves' disease.
    Dunkelmann, S
    Schuemichen, C
    Rudolph, F
    Prillwitz, A
    Groth, P
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 131P - 131P
  • [32] VANDERBILT EXPERIENCE WITH I-131 TREATMENT FOR GRAVES-DISEASE
    DOUGLAS, JG
    SOUTHERN MEDICAL JOURNAL, 1973, 66 (01) : 92 - 94
  • [33] OPTIMAL I-131 DOSE IN GRAVES-DISEASE - REPLY
    NORDYKE, RA
    GILBERT, FI
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (12) : 2360 - 2360
  • [34] Zum Auftreten einer Immunhyperthyreose nach Radiojodtherapie von SchilddrüsenautonomienPrevalence of graves’ disease following treatment of autonomous goiter with I-131 therapy
    Christine Hirsch
    Johann L. Spyra
    Heinz R. Langhammer
    Christian Laubenbacher
    Reingard Senekowitsch-Schmidtke
    Markus Schwaiger
    Medizinische Klinik, 1997, 92 (3) : 130 - 137
  • [35] ENDEMIC GOITER IN VENEZUELA STUDIED WITH I-131
    ROCHE, M
    DEVENANZI, F
    VERA, J
    COLL, E
    SPINETTIBERTI, M
    MENDEZMARTINEZ, J
    GERARDI, A
    FORERO, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1957, 17 (01): : 99 - 110
  • [36] DIFFUSE TOXIC GOITER TREATED WITH I-131
    GUZMAN, JR
    TREVINO, OG
    VAZQUEZ, CL
    MAISTERRENA, J
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1987, 39 (01): : 11 - 18
  • [37] ANALYSIS OF CURATIVE EFFECT AND INFLUENCING FACTORS OF 131I TREATMENT OF PATIENTS WITH GRAVES' DISEASE AND GIANT GOITER
    Gao, Yun
    Pan, Yi
    Wang, Ting-Ting
    Jia, Bing
    ACTA MEDICA MEDITERRANEA, 2020, 36 (02): : 1095 - 1099
  • [38] OUTCOME FOLLOWING STANDARDIZED 185 MBQ DOSE I-131 THERAPY FOR GRAVES-DISEASE
    WATSON, AB
    BROWNLIE, BEW
    FRAMPTON, CM
    TURNER, JG
    ROGERS, TGH
    CLINICAL ENDOCRINOLOGY, 1988, 28 (05) : 487 - 496
  • [39] The Outcome of I-131 Therapy for Graves Disease and Toxic Nodular, Multinodular Qoiter in Endemic Region
    Serdengecti, M.
    Sari, O.
    Ayan, A.
    Dostbil, Z.
    Ozturk, I. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S202 - S203
  • [40] I-131 THERAPY FOR GRAVES-DISEASE - MULTIVARIATE-ANALYSIS OF PRETREATMENT PARAMETERS AND OUTCOME
    TURNER, JG
    SADLER, WA
    BROWNLIE, BEW
    ROGERS, TGH
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (06): : 679 - 679
12345